BDR Pharma buys majority stake in Acme’s oral solids formulations business

Monday, November 9, 2026 - 20:39
0 1
BDR Pharma buys majority stake in Acme’s oral solids formulations business
Existing investors, including private equity firm PAG, are selling their stakes in Acme's oral solids formulations business in a transaction that is expected to value the business at about $250 million.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0

Comments (0)

User